Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Novartis AG
  6. News
  7. Summary
    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Swiss Exchange  -  11:30 2022-12-05 am EST
85.80 CHF   +1.97%
12:29pGloomy Eurozone Services PMI Weights on Sentiment as Most European Bourses End in the Red
MT
04:56aStifel Upgrades Recommendation on Novartis to Buy From Hold
MT
01:42aNovartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about NOVARTIS AG
04:56aStifel Upgrades Recommendation on Novartis to Buy From Hold
MT
01:42aNovartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
01:36aNovartis' Prostate Cancer Drug Extends Progression-free Survival In Late-stage Study
MT
01:16aNovartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
01:15aNovartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
DJ
01:15aNovartis AG Pluvicto Shows Statistically Significant and Clinically Meaningful Radiogra..
CI
12/01European Court Of Justice Issues Lan : No Repackaging/Rebranding As The Originator Referen..
AQ
11/30Transcript : Novartis AG - Special Call
CI
11/30Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
11/24Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study f..
AQ
11/23Novartis, Medicines for Malaria Venture to Kick Off Phase 3 Study for Uncomplicated Mal..
MT
11/23Novartis : and Medicines for Malaria Venture announce decision to move to Phase 3 study fo..
PU
11/22Novartis' Sandoz, Teva Pharmaceutical Partner To Expand Biosimilars Production
MT
11/22Generic drugmakers Teva and Sandoz make major push to biosimilars
RE
11/22Novartis highlights scientific advances with Kisqali, iptacopan, Scemblix and YTB323 da..
GL
More most relevant news
All news about NOVARTIS AG
12:29pGloomy Eurozone Services PMI Weights on Sentiment as Most European Bourses End in the R..
MT
04:56aStifel Upgrades Recommendation on Novartis to Buy From Hold
MT
01:42aNovartis Prostate Cancer Drug Trial Meets Primary Endpoint
DJ
01:36aNovartis' Prostate Cancer Drug Extends Progression-free Survival In Late-stage Study
MT
01:16aNovartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
01:15aNovartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
DJ
01:15aNovartis AG Pluvicto Shows Statistically Significant and Clinically Meaningful Radiogra..
CI
12/01European Court Of Justice Issues Lan : No Repackaging/Rebranding As The Originator Referen..
AQ
11/30Transcript : Novartis AG - Special Call
CI
11/30Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
More news
News in other languages on NOVARTIS AG
12:29pUn PMI des services morose dans la zone euro pèse sur le sentiment alors que la plupart..
12:16pAktien Schweiz Schluss: Wenig verändert - Novartis stützt
12:16pBourse Zurich: le SMI boucle à l'équilibre, investisseurs tiraillés
11:52aSchweizer Börse kommt zum Wochenbeginn nicht in die Gänge
11:48aBorsa svizzera: chiusura vicino al pareggio, SMI -0,03%
11:43aAktien Schweiz schließen kaum verändert - CS weiter erholt
11:39aNovartis: nouveau succès clinique du Pluvicto contre le cancer de la prostate
11:17aNovartis : titre en hausse, un broker ajuste son conseil
06:04aNovartis : Stifel revoit son opinion à la hausse
05:31aBourse Zurich: le SMI positif après l'emploi US, espoirs de relâchement en..
More news
Analyst Recommendations on NOVARTIS AG
04:56aStifel Upgrades Recommendation on Novartis to Buy From Hold
MT
11/30Intron Health Lifts Price Target on Novartis, Maintains Buy Recommendation
MT
11/22NOVARTIS AG : Gets a Sell rating from Deutsche Bank
MD
11/15Stifel Lifts Price Target on Novartis, Maintains Hold Recommendation
MT
11/10AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation
MT
More recommendations
Press releases
01:16aNovartis PluvictoTM shows statistically significant and clinically meaningful radiograp..
GL
12/01European Court Of Justice Issues Lan : No Repackaging/Rebranding As The Originator Referen..
AQ
11/24Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study f..
AQ
11/23Novartis : and Medicines for Malaria Venture announce decision to move to Phase 3 study fo..
PU
11/22Novartis highlights scientific advances with Kisqali, iptacopan, Scemblix and YTB323 da..
GL
More press releases
Analysis
Novartis earnings slip 4% on strong dollar, Gilenya competition
Stock Pick
 NOVARTIS AG
Back to basics
Stock Trading Strategies
TRADING
 Comeback of a rising trend?
Upcoming event on NOVARTIS AG
12/06/22San antonio breast cancer symposium - abstract number : #gs1-10
Upcoming sector events
01/24/23JOHNSON & JOHNSON : FY 2022 Earnings Release
01/27/23ABBVIE INC. : FY 2022 Earnings Release (Projected)
01/31/23PFIZER INC. : FY 2022 Earnings Release (Projected)
02/01/23NOVO NORDISK A/S : FY 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals